[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-333979-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-333979-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","loss-of-mir-634-contributes-to-the-formation-foxa1-positive-triple-negative-breast-cancer-subtype","Loss of miR-634 contributes to the formation FOXA1-positive triple negative breast cancer subtype","","Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited targeted treatment options, making its molecular pathogenesis a key research challenge. FOXA1 and miR-634 are implicated in tumor development, yet the mechanisms behind the abnormal upregulation of FOXA1 in TNBC remain unclear. This study investigates how miR-634 shapes the FOXA1-positive TNBC subtype through expression analyses, pathway and gene profiling, and functional assays.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/loss-of-mir-634-contributes-to-the-formation-foxa1-positive-triple-negative-breast-cancer-subtype/333979/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/loss-of-mir-634-contributes-to-the-formation-foxa1-positive-triple-negative-breast-cancer-subtype/333979.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in triple-negative breast cancer?","Question",{"text":63,"@type":64},"The study targets the challenge of limited targeted therapies in TNBC and the unclear molecular mechanism behind aberrant FOXA1 upregulation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was miR-634 expression measured in this research?",{"text":68,"@type":64},"Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect miR-634 levels in breast cancer tissues and cell lines.",{"name":70,"@type":61,"acceptedAnswer":71},"What key signaling pathway is implicated by the findings?",{"text":72,"@type":64},"The results indicate that inactivation of the PI3K/AKT signaling pathway is involved in miR-634-mediated suppression of FOXA1, proliferation, and metastasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},333979,1790193886,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Research  \nLoss of miR‑634 contributes to the formation FOXA1‑positive triple negative breast cancer subtype  \nFeng Ren1 · Xiaoping Rui2 · Xianqiu Xiao2  \nReceived: 13 April 2024 / Accepted: 17 October 2024  \n© The Author(s) 2024 OPEN  \nAbstract  \nBackground Triple-negative breast cancer (TNBC), the most aggressive subtype of breast cancer, lacks targeted therapies, posing a substantial challenge for treatment. Therefore, investigating its pathogenesis is a crucial research focus. FOXA1 and miR-634 are involved in tumorigenesis. However, the molecular mechanisms underlying the aberrant upregulation of FOXA1 expression inTNBC remain unclear. Therefore, we explore the role of miR-634 in the FOXA1-positive TNBC subtype. Methods Quantitative reverse transcription polymerase chain reaction was used to detect miR-634 expression in breast cancer tissues and cell lines. Aberrantly activated signaling pathways and related genes in TNBC were analyzed using The Cancer Genome Atlas. The potential target of miR-634 was predicted by TargetScan, the TNBC cell proliferation rate was detected using an MTT assay, the in vitro metastatic capacity was determined by transwell assay and the cell cycle distribution was tested using flow cytometry. Western blotting was performed to measure the expression of proteins involved in the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway.  \nResults The expression of miR-634 was significantly down-regulated in both TNBC tissues and cells, compared with adjacent non-cancerous tissues and MCF10A, respectively. Ectopic expression of miR-634 inhibits breast cancer cell proliferation and in vitro metastasis. TheTCGA-based expression profile analysis ofTNBC revealed that aberrantly activated PI3K/AKT signaling may contribute to its malignant phenotype. FOXA1, the top hit of aberrantly upregulated genes in TNBC, was a direct target of miR-643. Moreover, forced expression of miR-643 drastically suppressed FOXA1 expression by the inactivation PI3K/AKT signaling.  \nConclusion MiR-634 suppresses FOXA1 to inhibit the proliferation and metastasis ofTNBC cells by inactivating the PI3K/ AKT signaling pathway.  \n1 Introduction  \nTriple negative breast cancer (TNBC), accounts for 15% of all cases of breast cancer. This subtype is characterized by the absence of the estrogen receptor (ER), progesterone receptor, and HER2 expression or amplification [1]. TNBC is the most aggressive breast cancer subtype with a low response rate to drugs [2]. Accordingly, patients with TNBC typically have the worst prognosis [3]. Therefore, investigating its pathogenesis is a crucial research focus.  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-024-](https://doi.org/10.1007/s12672-024-)[ ](https://doi.org/10.1007/s12672-024-)[01472-5](01472-5.)[.](01472-5.)  \n* Xianqiu Xiao, [xiaoxianqiu2008@163.com |](xiaoxianqiu2008@163.com |1Department of Clinical Laboratory)[1](xiaoxianqiu2008@163.com |1Department of Clinical Laboratory)[Department of Clinical Laboratory](xiaoxianqiu2008@163.com |1Department of Clinical Laboratory), Affiliated Hospital of Jiangnan University, Wuxi 214122, Jiangsu, People’s Republic of China. 2Department of Thyroid and Breast Surgery, The 904th Hospital of the Joint Logistics Support Force of PLA, 101 Xingyuan Road, Wuxi 214044, Jiangsu, People’s Republic of China.  \nDiscover Oncology  \n(2024) 15:584  \n| [https://doi.org/10.1007/s12672-024-01472-5](https://doi.org/10.1007/s12672-024-01472-5)  \nWith the advancement of research, TNBC has been divided into additional subtypes for precise treatment [4] . Notably, a previously unrecognized subtype, the FOXA1-positive fraction, has a poor clinical outcome and is more prone to relapse [5] . Importantly, PIK3CA mutations are frequently found in FOXA1-positive TNBC [5] . Meanwhile, FOXA1 activates PI3K/AKT signaling to promote tumor progression [6] . However, the molecular mechanisms underlying the abe","cbCaieTHjeYaDcR6","https://ap.wps.com/l/cbCaieTHjeYaDcR6","pdf",1399991,"English","# Abstract\n# 1 Introduction\n# 2 Materials and methods\n## 2.1 Ethics statement\n## 2.2 Clinical samples","[{\"question\":\"What problem does the study address in triple-negative breast cancer?\",\"answer\":\"The study targets the challenge of limited targeted therapies in TNBC and the unclear molecular mechanism behind aberrant FOXA1 upregulation.\"},{\"question\":\"How was miR-634 expression measured in this research?\",\"answer\":\"Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect miR-634 levels in breast cancer tissues and cell lines.\"},{\"question\":\"What key signaling pathway is implicated by the findings?\",\"answer\":\"The results indicate that inactivation of the PI3K/AKT signaling pathway is involved in miR-634-mediated suppression of FOXA1, proliferation, and metastasis.\"}]","Loss of miR-634 contributes to the formation FOXA1-positive triple negative breast cancer subtype | PDF",1790004846,25]